23948sdkhjf
Log in or create to bookmark articles
Get access to all content on Life Science Nordic
No commitment or card information required
Applies to personal subscription only.
Contact us for a enterprise solution.
Advertisement
Advertisement

Sprint Bioscience builds the molecules that will become new medicines

In Sprint Bioscience’s laboratory in Flemingsberg, Huddinge, molecules are being created that no one has ever built before. The company specializes in preclinical drug development and has, in several cases, succeeded in securing deals and partnerships with larger pharmaceutical companies.
Advertisement

The liquid boils, bubbles, and simmers as medicinal chemists Johan Lindström and Matthieu Desroses methodically test their way forward. Their task is to find a way to build molecules with exactly the right shape, chemical composition, and properties required to bind to and block the target protein selected for this particular project.

Advertisement Advertisement
BREAKING
{{ article.headline }}
0.626|